Literature DB >> 25347695

Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview.

Alice S T Wong1, Chi-Ming Che, Kar-Wah Leung.   

Abstract

Cancer is one of the leading causes of death worldwide. Ginseng, a key ingredient in traditional Chinese medicine, shows great promise as a new treatment option. As listed by the U.S. National Institutes of Health as a complementary and alternative medicine, its anti-cancer functions are being increasingly recognized. This review covers the mechanisms of action of ginsenosides and their metabolites, which can modulate signaling pathways associated with inflammation, oxidative stress, angiogenesis, metastasis, and stem/progenitor-like properties of cancer cells. The emerging use of structurally modified ginsenosides and recent clinical studies on the use of ginseng either alone or in combination with other herbs or Western medicines which are exploited as novel therapeutic strategies will also be explored.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25347695     DOI: 10.1039/c4np00080c

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  81 in total

1.  Effects of various ginsenosides and ginseng root and ginseng berry on the activity of Pancreatic lipase.

Authors:  Zhipeng Li; Geun Eog Ji
Journal:  Food Sci Biotechnol       Date:  2017-06-08       Impact factor: 2.391

Review 2.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

Review 3.  Current Status and Problem-Solving Strategies for Ginseng Industry.

Authors:  Xiang-Yan Li; Li-Wei Sun; Da-Qing Zhao
Journal:  Chin J Integr Med       Date:  2019-10-15       Impact factor: 1.978

Review 4.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

Review 5.  Pharmacological properties of ginsenosides in inflammation-derived cancers.

Authors:  Do Luong Huynh; Nguyen Hoai Nguyen; Cuong Thach Nguyen
Journal:  Mol Cell Biochem       Date:  2021-04-26       Impact factor: 3.396

6.  Total ginsenosides synergize with ulinastatin against septic acute lung injury and acute respiratory distress syndrome.

Authors:  Rongju Sun; Yana Li; Wei Chen; Fei Zhang; Tanshi Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

7.  Dissipation and residues of the diamide insecticide chlorantraniliprole in ginseng ecosystems under different cultivation environments.

Authors:  Zhou Lu; Nan Fang; Yajuan Liu; Zhongbei Zhang; Hongyu Pan; Zhiguang Hou; Yueru Li; Zhongbin Lu
Journal:  Environ Monit Assess       Date:  2017-10-02       Impact factor: 2.513

8.  Protopanaxadiol and metformin synergistically inhibit estrogen-mediated proliferation and anti-autophagy effects in endometrial cancer cells.

Authors:  Chun-Jie Gu; Jiao Cheng; Bing Zhang; Shao-Liang Yang; Feng Xie; Jian-Song Sun; Li-Qing Huang; Jin-Jin Yu; Ming-Qing Li
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

9.  Inhibition of autophagosome-lysosome fusion by ginsenoside Ro via the ESR2-NCF1-ROS pathway sensitizes esophageal cancer cells to 5-fluorouracil-induced cell death via the CHEK1-mediated DNA damage checkpoint.

Authors:  Kai Zheng; Yan Li; Shaoxiang Wang; Xiao Wang; Chenghui Liao; Xiaopeng Hu; Long Fan; Qiangrong Kang; Yong Zeng; Xuli Wu; Haiqiang Wu; Jian Zhang; Yifei Wang; Zhendan He
Journal:  Autophagy       Date:  2016-06-16       Impact factor: 16.016

10.  Anticancer 20(R)-dammarane-3β,12β,20,25-tetrol-loaded polymeric micelles: Preparation, quantification and pharmacokinetics.

Authors:  Junxian Yu; Zhe Li; Wei Wang; Yang Zhang; Dandan Li; Yi Liu; Su Shen; Ruiwen Zhang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-04-01       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.